Autologous Platelet-Rich Plasma (PRP) for Chronic Non-Healing Wounds
Effective for claims with dates of service on or after August 2, 2012, CMS will cover autologous platelet-rich plasma (PRP) only for the treatment of chronic non-healing diabetic, venous and/or pressure wounds when PRP is provided under a clinical research study that meets specific requirements to assess the health outcomes of PRP for the treatment of chronic non-healing diabetic, venous and/or pressure wounds.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: June 10, 2013
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.